{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:11:07Z","timestamp":1793193067430,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012359","name":"Promotion and Mutual Aid Corporation for Private Schools of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.biomaterials.2013.08.036","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T10:15:34Z","timestamp":1377684934000},"page":"9220-9226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":229,"title":["Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles"],"prefix":"10.1016","volume":"34","author":[{"given":"T.","family":"Kanazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Seta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2013.08.036_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14728222.12.1.115","article-title":"Applying small RNA molecules to the directed treatment of human diseases: realizing the potential","volume":"12","author":"Pappas","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2174\/138955707782331678","article-title":"RNA interference as a tool for Alzheimer's disease therapy","volume":"7","author":"Orlacchio","year":"2007","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/187221109787158355","article-title":"CNS drug delivery systems: novel approaches","volume":"3","author":"Shadab","year":"2009","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib4","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.05.022","article-title":"Targeting the central nervous system: in\u00a0vivo experiments with peptide-derivatized nanoparticles loaded with loperamide and rhodamine-123","volume":"122","author":"Tosi","year":"2007","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate system for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib7","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib8","first-page":"46","article-title":"Intranasal delivery: bypassing the blood-brain barrier to deliver therapeutic agents to the brain and spinal cord","volume":"2","author":"Frey","year":"2002","journal-title":"Drug Deliv Technol"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations","volume":"40","author":"Thorne","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.02.011","article-title":"Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a noninvasive treatment strategy for multiple sclerosis","volume":"151","author":"Ross","year":"2004","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.2042-7158.1991.tb03510.x","article-title":"Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity","volume":"43","author":"Sakane","year":"1991","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1021\/bc0255900","article-title":"Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells","volume":"14","author":"Nori","year":"2003","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BA20050003","article-title":"Transdermal delivery of interferon-gamma (IFN-gamma) mediated by penetratin, a cell-permeable peptide","volume":"42","author":"Lee","year":"2005","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/bc9702157","article-title":"Poly caprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818","volume":"9","author":"Allen","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0169-409X(02)00226-0","article-title":"PEGylated nanoparticles for biological and pharmaceutical applications","volume":"55","author":"Otsuka","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2006.03.021","article-title":"Poly(ethylene glycol)\/poly (\u03b5-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection","volume":"113","author":"Jang","year":"2006","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(97)00164-8","article-title":"Methoxy poly(ethylene gricol)\/\u03b5-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization","volume":"51","author":"Shin","year":"1998","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0169-409X(02)00017-0","article-title":"Block copolymer micelles for delivery of gene and related compounds","volume":"54","author":"Kakizawa","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib21","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1021\/bm800876v","article-title":"Effects of the incorporation of hydrophobic middle block into a PEG\u2013polycation diblock copolymer on the physicochemical and cell interaction properties of the polymer\u2013DNA complexes","volume":"9","author":"Sharma","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2010.06.028","article-title":"Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery","volume":"396","author":"Tanaka","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejpb.2012.04.021","article-title":"Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles","volume":"81","author":"Kanazawa","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib24","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s11095-011-0440-7","article-title":"Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration","volume":"28","author":"Kanazawa","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2013.08.036_bib25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/ph5101092","article-title":"Intranasal delivery of camptothecin-loaded Tat-modified nanomicells for treatment of intracranial brain tumors","volume":"5","author":"Taki","year":"2012","journal-title":"Pharmaceuticals"}],"updated-by":[{"DOI":"10.1016\/j.biomaterials.2014.01.072","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000}}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213009848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213009848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T17:39:20Z","timestamp":1620927560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961213009848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":25,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0142961213009848"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.08.036","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.biomaterials.2014.01.072","asserted-by":"object"}]},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}